Vita Coco stock falls 2.72 percent after Zacks downgrade

Vita Coco stock fell 2.72 percent to USD 57.98 in Nasdaq trading on September 23, 2026, as Zacks downgraded the shares from strong buy to hold. The rating change follows a quarter in which revenue and earnings exceeded published estimates.

Zacks cuts rating to hold

According to MarketBeat on September 23, 2026, Zacks Research lowered Vita Coco from strong buy to hold. Wall Street Zen also moved its rating to hold, while the broader consensus remained Moderate Buy with an average price target of USD 76.86.

The downgrade contrasts with the company's second-quarter operating figures. Vita Coco reported diluted earnings per share of USD 0.82 for Q2/2026 versus a USD 0.56 consensus estimate, a USD 0.26 beat, according to MarketBeat.

Revenue expands 28.1 percent

Q2/2026 revenue reached USD 216.15 million, up 28.1 percent from the year-earlier period and above the USD 210.64 million estimate. The quarter also produced a 49 percent gross margin and a 29 percent operating margin, giving the rating change a clear valuation tension.

Vita Coco also raised its fiscal 2026 sales guidance to USD 790 million to USD 805 million, while adjusted EBITDA guidance stood at USD 154 million to USD 161 million, according to Investing.com. For investors, freight costs and the gap between earnings growth and the lower rating now define the debate.

Next earnings date is November 4

Nasdaq lists November 4, 2026 as Vita Coco's estimated next earnings date and shows a consensus EPS forecast of USD 0.51 for the coming quarter, according to Nasdaq. The stock's USD 57.98 price and USD 3,327,882,872 market capitalization as of September 24, 2026 place the next report against a measurable earnings and valuation test.